Matrix-assisted laser desorption/ionisation-imaging mass spectrometry (MALDI-IMS) is now an established imaging modality with particular utility in the study of biological, biomedical and pathological processes. In the first instance, the use of stable isotopically labelled (SIL) compounds in MALDI-IMS has addressed technical barriers to increase the accuracy and versatility of this technique. This has undoubtedly enhanced our ability to interpret the two-dimensional ion intensity distributions produced from biological tissue sections. Furthermore, studies using delivery of SIL compounds to live tissues have begun to decipher cell, tissue and inter-tissue metabolism while maintaining spatial resolution. Here, we review both the technical and biological applications of SIL compounds in MALDI-IMS, before using the uptake and metabolism of glucose in bovine ocular lens tissue to illustrate the current limitations of SIL compound use in MALDI-IMS. Finally, we highlight recent instrumentation advances that may further enhance our ability to use SIL compounds in MALDI-IMS to understand biological and pathological processes. Graphical Abstract.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00216-021-03189-8DOI Listing

Publication Analysis

Top Keywords

sil compounds
16
compounds maldi-ims
12
pathological processes
8
maldi-ims
5
sil
5
applications stable
4
stable isotopes
4
isotopes maldi
4
maldi imaging
4
imaging current
4

Similar Publications

The combustion of diesel in engines contributes polycyclic aromatic hydrocarbons to Diesel Particulate Matter (DPM) present in the atmosphere, therefore causing toxic mitigating consequences by eliciting oxidative modulation. Currently, type 2 diabetes mellitus is reported as a global menace, causing about 1.5 million deaths in 2019 and contributing to about 48% of related deaths among the populace aged below 70 years.

View Article and Find Full Text PDF

SLNP-based CDK4- targeted nanotherapy against glioblastoma.

Front Oncol

November 2024

Molecular Immunology Laboratory, Department of Healthcare Biotechnology, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan.

Introduction: Glioblastoma is a grade IV solid brain tumor and has a 15-month survival rate even after treatment. Glioblastoma development is heavily influenced by retinoblastoma protein (pRB) pathway changes. The blood-brain barrier, drug resistance, and severe toxicity of Temozolamide are key obstacles in treating glioblastoma.

View Article and Find Full Text PDF
Article Synopsis
  • Metabolomics using HILIC-MS is effective for identifying polar metabolites and aiding in biomarker discovery, but matrix effects can complicate biological analysis.
  • Evaluation of matrix effects is critical in method development, and this study tested two techniques: stable isotope labeled-internal standards and post-column infusion (PCI).
  • Results indicated that the PCI method is more advantageous for untargeted analysis, showing better performance in assessing matrix effects and highlighting significant ion suppression in various plasma samples.
View Article and Find Full Text PDF

HDAC8 and HDAC2 are recently reported to be overexpressed in cervical cancer. To date, studies related to the use of dual targeted HDAC inhibitor to treat cervical cancer are not well explored. Again, majority of the selective HDAC inhibitors discovered so far are hydroxamic acids, which have multiple adverse side-effects due to their strong zinc chelating ability.

View Article and Find Full Text PDF

To investigate dietary influences on the volatilome, the volatile subcategory of the metabolome, we performed a comparative untargeted volatilome analysis of exhaled breath, ruminal fluid, serum, urine, and milk from lactating Holstein cows fed different diets. Thirty-two cows (79.4 ± 31.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!